Radovich Peter 4
4 · Mirum Pharmaceuticals, Inc. · Filed Mar 5, 2025
Insider Transaction Report
Form 4
Radovich Peter
PRESIDENT AND COO
Transactions
- Sale
Common Stock
2025-03-04$45.57/sh−13,681$623,458→ 13,280 total - Sale
Common Stock
2025-03-04$45.74/sh−1,169$53,470→ 12,111 total
Footnotes (1)
- [F1]The weighted average sale price for the transaction reported was $45.571143, and the range of prices were between $45.50 and $45.88. Upon request by the SEC staff, the Issuer, or any security holder of the Issuer, full information regarding the number of shares sold at each separate price will be provided.